TNF and ankylosing spondylitis: As TNFα blockade is known to be an exceedingly effective therapeutic approach in many patients with ankylosing spondylitis, the effects of apremilast in ankylosing spondylitis are currently being tested in a phase II, randomised, double-blinded, clinical control study at our centre.